Skip to main content
. Author manuscript; available in PMC: 2018 Sep 19.
Published in final edited form as: Immunity. 2017 Sep 12;47(3):498–509.e6. doi: 10.1016/j.immuni.2017.08.007

Figure 3. Loss of SIDT2 impairs innate immunity to HSV-1 infection.

Figure 3

(A) Vero cells were infected with 1 MOI GFP-tagged HSV-1 virus for 24 h, stained with J2 anti-dsRNA antibody (red) and DAPI (blue), and imaged by confocal microscopy. In the absence of HSV-1 infection, no dsRNA was evident (top panel), whereas following HSV-1 challenge dsRNA was readily observed in uninfected cells (bottom panel, arrows). Data are representative of three independent experiments. Scale bar = 20 μm. (B) Sidt2+/+ and Sidt2−/− MEFs were infected with 1 MOI mCherry-tagged HSV-1 virus for the indicated times and analysed by flow cytometry. Data is representative of 3 independent experiments. Error bars represent mean ± SEM. (C) Cell culture supernatant from Sidt2+/+ and Sidt2−/− MEFs infected with 1 MOI mCherry-tagged HSV-1 was collected at 96 h p.i. and IFN-β was measured via ELISA. (D) Sidt2+/+ and Sidt2−/− mice (n=13–15) were infected with 1×107 PFU HSV-1 i.p. and survival monitored for 8 days. (E–F) Serum from Sidt2+/+ and Sidt2−/− mice (n=10–13) was collected at 8h and 16h p.i. respectively and serum IFNβ was measured via ELISA. (G–H) Serum IL-6 and RANTES from Sidt2+/+ and Sidt2−/− mice (n=10–13) at 16 h p.i. were measured using Bioplex bead assay. For panels E–H, data are plotted as mean ± SEM. * P < 0.05, *** P < 0.001, n.s. = not significant. Data represents the pooled results from 3 independent experiments. See also Figure S3.